Publication | Open Access
Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma
66
Citations
30
References
2021
Year
NCT03556046-14th of June, 2018.
| Year | Citations | |
|---|---|---|
Page 1
Page 1